4//SEC Filing
Glenning Robert 4
Accession 0001209191-22-014999
CIK 0000827871other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:57 PM ET
Size
5.4 KB
Accession
0001209191-22-014999
Insider Transaction Report
Form 4
Glenning Robert
Director
Transactions
- Award
Stock Option (right to buy)
2022-02-28+11,200→ 11,200 totalExercise: $47.39Exp: 2032-02-28→ Common Stock (11,200 underlying)
Footnotes (1)
- [F1]The option fully vests on February 28, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001678676
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:57 PM ET
- Size
- 5.4 KB